Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Natural Remedies

Presentation Of The National Consortium For Translational Cancer Research
No progress without research - this is particularly true for cancer medicine. The chances of cure for those affected can only be further increased if research results are swiftly transferred from the laboratory into clinical practice. Framework conditions for this research transfer, also called translational research, will now be optimized in Germany. Last Tuesday, German Research Minister Annette Schavan, Friedrich Carl Janssen, Chairman of German Cancer Aid (Deutsche Krebshilfe), and Professor Dr. Otmar D. Wiestler, Scientific Director of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) presented the "National Consortium for Translational Cancer Research" in Berlin.
generic viagra online
Nearly One Half Of All Deaths On The Road Are Pedestrians, Cyclists And Motorcyclists, New WHO Study Reveals
The first global assessment of road safety finds that almost half of the estimated 1.27 million people who die in road traffic crashes each year are pedestrians, motorcyclists and cyclists. While progress has been made towards protecting people in cars, the needs of these vulnerable groups of road users are not being met.
News of the day
Maintaining Cognitive Function In Old Age
Not everyone declines in cognitive function with age. Elderly people who exercise at least once a week, have at least a high school education and a ninth grade literacy level, are not smokers and are more socially active are more likely to maintain their cognitive skills through their 70s and 80s, according to research published in the June 9, 2009, print issue of Neurology®, the medical journal of the American Academy of Neurology.
Oncology

Institute For Oneworld Health Announces Successful Collaboration To Fight Neglected Diarrheal Diseases In Developing Countries

The Institute for OneWorld Health, the US-based non-profit pharmaceutical company that develops drugs for people with neglected infectious diseases in the developing world, today announced that it has successfully completed its first screening campaign of the Roche proprietary compound library and will select up to 40 new drug leads for further study intended to identify a new treatment for childhood diarrhea. OneWorld Health and Roche, a multinational pharmaceutical company with headquarters in Basel, Switzerland, and a global research presence, entered into a research collaboration in the spring of 2008 to fight neglected diarrheal diseases, which kill nearly two million children under the age of five in the developing world each year. "Our work with Roche is an example of the different kinds of partnerships required to make the goal of reducing childhood deaths from diarrheal diseases in the developing world a reality," said Dr. Richard Chin, OneWorld Health"s Chief Executive Officer. "The world has shown its resolve to fight pediatric diarrheal diseases by committing to the UN Millennium Development Goal of reducing the child mortality rate by two-thirds by 2015." OneWorld Health is a member of a coalition of more than 75 organizations (http://www.eddcontrol.org/call-to-action.php ) calling for action by the international community to stop needless deaths caused by diarrheal diseases. The coalition yesterday released two vital reports outlining the approaches and res necessary to stem the tide of diarrheal deaths at a high-level forum in Washington, DC, convened by PATH and WaterAid America. Diarrheal diseases-cholera, rotavirus, shigellosis, and others-are the second leading killer of children under the age of five in the developing world. OneWorld Health is working with its partners to discover and develop novel anti-secretory diarrheal drugs that will reduce fluid loss and help prevent death from dehydration caused by acute watery diarrheal diseases. This treatment is intended to be used as an adjunct to Oral Rehydration Therapy and zinc to save the lives of infants and children. OneWorld Health commissioned BioFocus DPI to perform high-throughput screening of more than 780,000 molecules from Roche"s compound library in search of potential leads for its diarrheal diseases program, and will follow up on these leads to assemble a portfolio of drug candidates that address various aspects of diarrheal diseases. Institute for OneWorld Health and Roche


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009